MSH2 and carcinoma: The dMMR was identified by the lack of protein expression from the MMR genes, including MLH1, MSH2, and MSH6, which were associated with distinct clinicopathological features, such as a well-differentiated carcinomas, early-stage rectal carcinomas and better prognoses [19].